Danaher raises 2026 adjusted EPS guidance to $8.57-$8.62 after Q3 revenue rises 8.5%
Danaher reported third-quarter 2026 sales of $6.6 billion, up 8.5% year over year, and net earnings of $1.2 billion, or $1.71 per diluted share, up 34.5%. Adjusted diluted EPS rose 11.5% to $2.11, and the company raised its full-year 2026 adjusted EPS guidance to $8.57-$8.62 from $8.45-$8.60. For shareholders, the results and higher guidance point to stronger profit, though core revenue growth excluding respiratory testing was 5.5%, and the company expects respiratory testing to be a headwind in the fourth quarter.
Key points
- Third-quarter net earnings were $1.2 billion, or $1.71 per diluted share, up 34.5% year over year.
- Adjusted diluted EPS was $2.11, up 11.5% from $1.89 a year earlier.
- Full-year 2026 adjusted diluted EPS guidance was raised to $8.57-$8.62 from $8.45-$8.60.
- Core revenue excluding respiratory testing rose 5.5%; total core revenue rose 3.0%.
The filing
Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.